DK3362446T3 - Dopamin-d3-receptorantagonister med en morpholindel - Google Patents
Dopamin-d3-receptorantagonister med en morpholindel Download PDFInfo
- Publication number
- DK3362446T3 DK3362446T3 DK16784245.9T DK16784245T DK3362446T3 DK 3362446 T3 DK3362446 T3 DK 3362446T3 DK 16784245 T DK16784245 T DK 16784245T DK 3362446 T3 DK3362446 T3 DK 3362446T3
- Authority
- DK
- Denmark
- Prior art keywords
- dopamin
- receptor antagonists
- morpholine
- morpholine part
- antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1518124.1A GB2543296A (en) | 2015-10-13 | 2015-10-13 | Dopamine D3 receptor antagonists having a morpholine moiety |
| PCT/GB2016/053169 WO2017064488A1 (en) | 2015-10-13 | 2016-10-13 | Dopamine d3 receptor antagonists having a morpholine moiety |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3362446T3 true DK3362446T3 (da) | 2021-01-04 |
Family
ID=55130992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16784245.9T DK3362446T3 (da) | 2015-10-13 | 2016-10-13 | Dopamin-d3-receptorantagonister med en morpholindel |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10577361B2 (da) |
| EP (1) | EP3362446B1 (da) |
| AU (1) | AU2016338992B2 (da) |
| CA (1) | CA3001649C (da) |
| DK (1) | DK3362446T3 (da) |
| ES (1) | ES2839407T3 (da) |
| GB (1) | GB2543296A (da) |
| IL (1) | IL258606B (da) |
| NZ (1) | NZ741384A (da) |
| SG (1) | SG11201802941TA (da) |
| WO (1) | WO2017064488A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019146740A1 (ja) | 2018-01-26 | 2019-08-01 | 塩野義製薬株式会社 | ドーパミンｄ３受容体拮抗作用を有する環式化合物 |
| CN110407763B (zh) * | 2019-08-08 | 2022-10-14 | 苏州汉德创宏生化科技有限公司 | 一种4-(噁唑-2-基)苯甲酸的合成方法 |
| CN116459341B (zh) * | 2023-03-15 | 2024-03-19 | 徐州医科大学 | 多巴胺3型受体作为靶点在开发或制备非阿片类镇痛药物中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1058060B (de) * | 1956-09-12 | 1959-05-27 | Ravensberg G M B H Chmische Fa | Verfahren zur Herstellung von analgetisch wirksamen, substituierten ªÏ-Morpholinoalkylaethern des Salicylamids |
| FR2094499A5 (en) * | 1970-06-23 | 1972-02-04 | Aries Robert | Phenoxyalkanoic acid morpholides - with hypocholesterolaemic and anorectic activity |
| JPS6061569A (ja) * | 1983-09-16 | 1985-04-09 | Asahi Chem Ind Co Ltd | 新規な３位置換アミン誘導体 |
| GB8720910D0 (en) | 1987-09-05 | 1987-10-14 | Pfizer Ltd | Antiarrhythmic agents |
| JPH072848A (ja) | 1993-04-23 | 1995-01-06 | Sankyo Co Ltd | モルホリンおよびチオモルホリン誘導体 |
| WO2004052372A1 (en) | 2002-12-10 | 2004-06-24 | Pfizer Limited | Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction |
| JP4198183B2 (ja) * | 2004-05-27 | 2008-12-17 | ファイザー・インク | 選択的ドーパミンｄ３アゴニストとしてのアミノピリジン誘導体 |
| GB0502509D0 (en) * | 2005-02-07 | 2005-03-16 | Pfizer Ltd | Novel salt form of a dopamine agonist |
| WO2008026046A1 (en) | 2006-08-30 | 2008-03-06 | Pfizer Products Inc. | Morpholine d3 dopamine antagonists |
| GB0700786D0 (en) * | 2007-01-15 | 2007-02-21 | Pfizer Ltd | Morpholine dopamine agonists for the treatment of pain |
-
2015
- 2015-10-13 GB GB1518124.1A patent/GB2543296A/en not_active Withdrawn
-
2016
- 2016-10-13 EP EP16784245.9A patent/EP3362446B1/en active Active
- 2016-10-13 CA CA3001649A patent/CA3001649C/en active Active
- 2016-10-13 NZ NZ741384A patent/NZ741384A/en unknown
- 2016-10-13 SG SG11201802941TA patent/SG11201802941TA/en unknown
- 2016-10-13 DK DK16784245.9T patent/DK3362446T3/da active
- 2016-10-13 ES ES16784245T patent/ES2839407T3/es active Active
- 2016-10-13 US US15/767,328 patent/US10577361B2/en active Active
- 2016-10-13 WO PCT/GB2016/053169 patent/WO2017064488A1/en active Application Filing
- 2016-10-13 AU AU2016338992A patent/AU2016338992B2/en active Active
-
2018
- 2018-04-10 IL IL258606A patent/IL258606B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ741384A (en) | 2022-11-25 |
| CA3001649A1 (en) | 2017-04-20 |
| IL258606B (en) | 2022-02-01 |
| AU2016338992B2 (en) | 2020-10-08 |
| US10577361B2 (en) | 2020-03-03 |
| EP3362446B1 (en) | 2020-12-02 |
| IL258606A (en) | 2018-06-28 |
| SG11201802941TA (en) | 2018-05-30 |
| CA3001649C (en) | 2023-04-04 |
| WO2017064488A1 (en) | 2017-04-20 |
| GB2543296A (en) | 2017-04-19 |
| AU2016338992A1 (en) | 2018-04-26 |
| US20180297990A1 (en) | 2018-10-18 |
| ES2839407T3 (es) | 2021-07-05 |
| EP3362446A1 (en) | 2018-08-22 |
| GB201518124D0 (en) | 2015-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3666771T3 (da) | Lpa-antagonister | |
| DK3440102T3 (da) | T-cellereceptorer | |
| DK3448882T3 (da) | Anti-kk-lc-1-t-cellereceptorer | |
| DK3368060T3 (da) | Glugacon-receptor-agonister | |
| DK3143037T3 (da) | Alpha4beta7-integrin-thioether-peptidantagonister | |
| DK3515887T3 (da) | TRPV4-antagonister | |
| DK3331886T3 (da) | Dopamin-d3-receptorantagonister med en bicyclo-del | |
| DK3155209T3 (da) | Brøndværktøj med dobbeltfunktion | |
| DK3212637T3 (da) | Dopamin-d3-receptorantagonistforbindelser | |
| IL247081A0 (en) | Thiazole or oxazole are converted p2x7 receptor antagonists | |
| DK3334721T3 (da) | Cgrp-receptorantagonister | |
| DK3122667T3 (da) | Tilførselsenhed | |
| GB201519194D0 (en) | CGRP receptor antagonists | |
| DK3362446T3 (da) | Dopamin-d3-receptorantagonister med en morpholindel | |
| DK3035303T3 (da) | Returautomat | |
| DK3310756T3 (da) | Thromboxanreceptorantagonister | |
| DK3310762T3 (da) | Hidtil ukendte 5-ht2-antagonister | |
| GB201519195D0 (en) | CGRP Receptor Antagonists | |
| FR3022477B1 (fr) | Machine de percage | |
| FR3016665B1 (fr) | Element a visser | |
| NO20141516A1 (no) | Plaster | |
| FR3020960B1 (fr) | Harnais antichute a double reglage | |
| FI20140123A (fi) | Saneeraussukka | |
| DK3464324T3 (da) | Angiotensin-1-receptorantagonister | |
| FR3034118B1 (fr) | Tuile a emboitement |